FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/02/104151 [Registered on: 18/02/2026] Trial Registered Prospectively
Last Modified On: 17/02/2026
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Comparison between Propofol and Etomidate affect on haemodynamic changes, seizure duration and recovery time In modified ect. 
Scientific Title of Study   EFFECT OF PROPOFOL VERSUS ETOMIDATE ON SEIZURE DURATION, HEMODYNAMIC CHANGES AND RECOVERY TIME IN MODIFIED ECT. 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Nishtha Goel 
Designation  PG Resident Anesthesia Second Year 
Affiliation  Pacific Medical College and Hospital  
Address  Pacific Medical College and Hospital, Bhilon ka Bedla, Udaipur,
Pacific Medical College and Hospital, Bhilon ka Bedla, Udaipur.
Udaipur
RAJASTHAN
313001
India 
Phone  7988078407  
Fax    
Email  nishthagoel7@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Prakash Audichya 
Designation  Professor and Head of department Anaesthesia 
Affiliation  Pacific Medical College and Hospital  
Address  Pacific Medical College and Hospital, Bhilon ka Bedla, Udaipur.
Pacific Medical College and Hospital, Bhilon ka Bedla, Udaipur.
Udaipur
RAJASTHAN
313001
India 
Phone  9929721889  
Fax    
Email  prakash.audichya10@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Nishtha Goel 
Designation  PG Resident Anesthesia Second Year 
Affiliation  Pacific Medical College and Hospital  
Address  Pacific Medical College and Hospital, Bhilon ka Bedla, Udaipur,
Pacific Medical College and Hospital, Bhilon ka Bedla, Udaipur,
Udaipur
RAJASTHAN
313001
India 
Phone  9929721889  
Fax    
Email  nishthagoel7@gmail.com  
 
Source of Monetary or Material Support  
Department of anesthesiology and critical care, 3rd floor, Pacific Medical College and Hospital, Udaipur, Rajesthan- 313001 
 
Primary Sponsor  
Name  Pacific Medical College and Hospital 
Address  Pacific Medical College and Hospital, Bhilon ka Bedla, N.H. 27, Pratap Pura, Girwa, Udaipur, Rajasthan 313001 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Nishtha Goel  Pacific Medical College And Hospital   Pacific Medical College and Hospital, Department of anesthesiology and critical care,3rd floor, Bhilon ka Bedla, Udaipur, Rajasthan 313001 Udaipur RAJASTHAN
Udaipur
RAJASTHAN 
7988078407

nishthagoel7@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee,Pacific Medical College and Hospital   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: F333||Major depressive disorder, recurrent, severe with psychotic symptoms,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  ETOMIDATE   Injection Etomidate I/v 0.2 mg/kg over 120 seconds  
Intervention  PROPOFOL  Injection Propofol i/v 2mg/kg over120 seconds  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1 Patients relative given consent
2 ASA GRADE I AND II
3 Age range Adults aged 18 years to 50 years
4 ECT Indication Patients diagnosed with psychiatric conditions for which ECT is indicated 
 
ExclusionCriteria 
Details  1 Patients relative refusal
2 ASA Grade more than 2
3 Known Allergy Patients with a known allergy or adverse reaction to study drug
4 Severe Cardiovascular Disorders Individuals with severe uncontrolled cardiovascular conditions e.g unstable angina recent myocardial infarction
5 Pregnancy and Lactation Pregnant or Lactating women
6 Epilepsy
7 Neuromuscular disorder
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
For better knowledge of how patients respond to propofol and etomidate before, during and after Electro Convulsive Therapy (ECT) in order to better comprehend the anesthetic impact.   3 months 
 
Secondary Outcome  
Outcome  TimePoints 
To report any adverse effects   24 months 
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is to compare the effect between Propofol and Etomidate on seizure duration, Hemodynamic changes and the recovery time in modified Electro Convulsion Therapy.
It is prospective double blinded study
 
Close